Publication | Closed Access

Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study

EpidemiologyAntifungal AgentFungal PathogenAntifungal AgentsMedicineClinical EpidemiologyHematologyPathologyInvasive Fungal DiseasesClinical Risk ScoreChina AssessmentPublic HealthOncologyCancer Research